Two Sigma Investments’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.44M | Sell |
96,809
-84,342
| -47% | -$6.58M | 0.01% | 1651 |
|
|
2025
Q4 | $14.3M | Buy |
181,151
+127,368
| +237% | +$11M | 0.02% | 900 |
|
|
2025
Q3 | $4.93M | Buy |
+53,783
| New | +$4.39M | 0.01% | 1475 |
|
|
2025
Q2 | – | Sell |
-14,079
| Closed | -$943K | – | 3168 |
|
|
2025
Q1 | $943K | Buy |
+14,079
| New | +$841K | ﹤0.01% | 2213 |
|
|
2024
Q4 | – | Sell |
-5,706
| Closed | -$340K | – | 3188 |
|
|
2024
Q3 | $340K | Sell |
5,706
-1,600
| -22% | -$97.6K | ﹤0.01% | 2627 |
|
|
2024
Q2 | $465K | Sell |
7,306
-5,539
| -43% | -$360K | ﹤0.01% | 2405 |
|
|
2024
Q1 | $888K | Sell |
12,845
-13,905
| -52% | -$839K | ﹤0.01% | 2026 |
|
|
2023
Q4 | $1.47M | Buy |
+26,750
| New | +$1.47M | ﹤0.01% | 1828 |
|
|
2023
Q3 | – | Sell |
-10,406
| Closed | -$560K | – | 2941 |
|
|
2023
Q2 | $560K | Buy |
+10,406
| New | +$461K | ﹤0.01% | 2283 |
|
|
2022
Q2 | – | Sell |
-44,863
| Closed | -$1.26M | – | 2487 |
|
|
2022
Q1 | $1.26M | Sell |
44,863
-66,617
| -60% | -$2.48M | ﹤0.01% | 1591 |
|
|
2021
Q4 | $5.14M | Buy |
111,480
+86,817
| +352% | +$3.73M | 0.01% | 1182 |
|
|
2021
Q3 | $809K | Sell |
24,663
-11,365
| -32% | -$353K | ﹤0.01% | 2808 |
|
|
2021
Q2 | $1.26M | Sell |
36,028
-26,988
| -43% | -$918K | ﹤0.01% | 2277 |
|
|
2021
Q1 | $2.28M | Sell |
63,016
-18,016
| -22% | -$564K | 0.01% | 1601 |
|
|
2020
Q4 | $2.35M | Buy |
81,032
+5,497
| +7% | +$157K | 0.01% | 1394 |
|
|
2020
Q3 | $2.13M | Buy |
75,535
+10,148
| +16% | +$302K | 0.01% | 1258 |
|
|
2020
Q2 | $2.12M | Buy |
+65,387
| New | +$2.34M | 0.01% | 1067 |
|
|
2019
Q3 | – | Sell |
-15,200
| Closed | -$1.25M | – | 3426 |
|
|
2019
Q2 | $1.25M | Buy |
15,200
+5,600
| +58% | +$398K | ﹤0.01% | 1756 |
|
|
2019
Q1 | $677K | Buy |
+9,600
| New | +$565K | ﹤0.01% | 2071 |
|
|
2018
Q2 | – | Sell |
-18,100
| Closed | -$1.05M | – | 3279 |
|
|
2018
Q1 | $1.05M | Buy |
18,100
+1,440
| +9% | +$91.4K | ﹤0.01% | 1975 |
|
|
2017
Q4 | $1.07M | Buy |
+16,660
| New | +$1.04M | ﹤0.01% | 1918 |
|
|
2016
Q1 | – | Sell |
-10,916
| Closed | -$493K | – | 2768 |
|
|
2015
Q4 | $493K | Buy |
+10,916
| New | +$470K | ﹤0.01% | 1977 |
|
|
2015
Q1 | – | Sell |
-28,054
| Closed | -$1.58M | – | 2611 |
|
|
2014
Q4 | $1.58M | Buy |
+28,054
| New | +$1.24M | 0.01% | 1140 |
|
|
2014
Q2 | – | Sell |
-19,613
| Closed | -$615K | – | 2131 |
|
|
2014
Q1 | $615K | Buy |
+19,613
| New | +$520K | ﹤0.01% | 1398 |
|
Other funds holding ANIP
VCM
SCM
TCM
GAM
DTC
Two Sigma Investments's ANIP Position: Q1 2026 in Review
Two Sigma Investments reduced its ANI Pharmaceuticals (ANIP) stake by 47% in Q1 2026, selling an estimated $6.58M and leaving 96,809 shares worth $7.44M. The position accounts for 0.01% of the portfolio, ranked #1651.
Two Sigma Investments first reported a position in ANIP in Q1 2014 and has held it in 24 quarters since. The position peaked at $14.3M in Q4 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.
- Two Sigma Investments held 96,809 shares of ANI Pharmaceuticals worth $7.44M as of Q1 2026.
- Two Sigma Investments sold 84,342 ANI Pharmaceuticals shares in Q1 2026, an estimated $6.58M.
- ANI Pharmaceuticals made up 0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1651 holding.
- Two Sigma Investments first reported a position in ANI Pharmaceuticals in Q1 2014 and has held it in 24 quarters since.
- Two Sigma Investments's ANI Pharmaceuticals position peaked at $14.3M in Q4 2025.
- 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.